Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases

NCT04637256 | Completed

• 1 other identifier: 037.HPB.2018.R
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

This study will be a retrospective chart review of patients who have been diagnosed with benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas. The Investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either the investigator's patients from their practice or through a national database. Data will be analyzed primarily by the study conductors.

Conditions

Pancreatic Malignant Neoplasm Primary

Outcome Measures

Primary Outcomes (1)

• Overall Survival

  We will be examining all treatments of benign or malignant pancreatic cancer by measuring the following outcome: overall survival

  2005 to 2019

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All past patients who were treated for a particular benign or malignant gastroesophageal disease process under evaluation from 2005 to present will be included in this study.

You may qualify if:

• All patients diagnosed and treated for gastroesophageal diseases, benign or malignant from 2005 to present.
• Age ≥18 years

You may not qualify if:

• Patients that are not diagnosed with or treated for gastroesophageal diseases
• Age \< 18 years

Sponsors & Collaborators

• Methodist Health System: lead

Study Sites (1)

Trinity Surgical Consultants, Methodist Richardson Medical Center

Richardson, Texas, 75082, United States

Location

Study Officials

• Dhiresh Jeyarajah, M.D.

  Methodist Health System

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 22, 2019
• First Posted: November 19, 2020
• Study Start: March 6, 2019
• Primary Completion: February 27, 2021
• Study Completion: March 1, 2021
• Last Updated: June 10, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)